Altre lingue Glenmark Life Sciences Limited Bombay S.E.

Azioni

GLS

INE03Q201024

Mercato chiuso - Bombay S.E. Altri mercati azionari 12:00:48 19/04/2024			Variaz. 5gg	Var. 1 gen.
802,4 ^INR	+0,41%		-0,85%	+22,11%

12/03	Nirma Limited ha completato l'acquisizione del 75% di Glenmark Life Sciences Limited (NSEI:GLS) da Glenmark Pharmaceuticals Limited (NSEI:GLENMARK) (GPL).	CI
06/03	Glenmark Life Sciences Limited annuncia le dimissioni dal Consiglio di Amministrazione, con effetto dal 6 marzo 2024	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Nirma Limited completed the acquisition of 75% stake in Glenmark Life Sciences Limited from Glenmark Pharmaceuticals Limited.	12/03
Glenmark Life Sciences Limited Announces Board Resignations, Effective March 6, 2024	06/03
Nirma Limited completed the acquisition of 0.000738% stake in Glenmark Life Sciences Limited.	29/02
Glenmark Pharmaceuticals Ltd. reports Consolidated Revenue of Rs. 29,096 Mn for Q3 FY 2023 24	15/02
India's Glenmark Pharma posts loss for Q3 as remediation cost weighs	14/02
India's Glenmark Life Sciences posts Q3 profit rise; strong orderbook ahead, says CEO	23/01
Glenmark Life Sciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	23/01
Paracetamol maker Granules India posts marginal rise in Q3 profit	23/01
Glenmark Life Signs Master Supply Agreement with Japanese Drugmaker for Urinary Anti-Spasmodic API	19/01
Glenmark Life Sciences Announces Another CDMO Deal	19/01
India's Glenmark Pharma posts Q2 loss on exceptional legal costs	10/11
Paracetamol maker Granules India's Q2 revenue rises on higher N.America demand	09/11
India's Glenmark Life Sciences posts Q2 profit rise on API boost	20/10/23
Glenmark Life Sciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	20/10/23
Glenmark Life Sciences Limited Declares Interim Equity Dividend for the Financial Year 2023-24, Payable on or After October 23, 2023	09/10/23
Indian paracetamol maker Valiant Laboratories lists at 16% premium	06/10/23
Fitch Affirms Glenmark Pharmaceuticals at 'BB'; Outlook Stable	04/10/23
Glenmark Life Sciences Limited Approves Interim Dividend for the Financial Year 2022-23	26/09/23
Glenmark Pharmaceuticals to Divest Majority Stake in Glenmark Life Sciences for INR56.5 Billion	22/09/23
INDIA STOCKS-Indian shares set for subdued open as Fed angst weighs	22/09/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Glenmark Life Sciences Limited Bombay S.E.

Azioni

GLS

INE03Q201024

Altre lingue

Filtri